BEST Vet: Building Employment Skills Through Therapy for Veterans

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT01992913
Collaborator
(none)
74
1
2
62.7
1.2

Study Details

Study Description

Brief Summary

Schizophrenia/Schizoaffective Disorder is associated with serious problems with cognitive skills, social skills, and functional skills (like employment). There is a new form of cognitive behavioral therapy called integrated cognitive behavioral therapy (iCBT) that specifically addresses the cognitive, social, and functional deficits of schizophrenia/schizoaffective disorder. This study compared iCBT to the usual care (UC) that Veteran's receive. The investigators compared iCBT to UC in subjects with schizophrenia/schizoaffective disorder who are enrolled in a Supported Employment (SE) program, and evaluate whether iCBT is more helpful in improving job performance, and other areas of functioning, both right after treatment, and 6 months after the end of treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: integrated Cognitive Behavioral Therapy
  • Other: Usual Care
  • Behavioral: Computerized cognitive remediation (CCR)
N/A

Detailed Description

The objective of the current study was to evaluate whether integrated cognitive behavior therapy (iCBT) can improve engagement and success in an existing Supported Employment (SE) program among the most functionally disabled patients with schizophrenia/schizoaffective disorder. The iCBT condition also included computerized cognitive remediation. The primary specific aim was to determine whether iCBT will significantly improve work outcomes at post-treatment to a greater extent than Usual Care (UC) in low functioning patients with schizophrenia/schizoaffective disorder who join the SE program. The secondary aims were to evaluate the whether iCBT will significantly improve work outcomes at 6 month follow-up relative to UC, and whether iCBT will improve functional outcomes post-treatment and at follow-up relative to UC in subjects who join the SE program.

Study Design

Study Type:
Interventional
Actual Enrollment :
74 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Integrated Cognitive Behavior Therapy to Improve Work Outcomes in Schizophrenia
Actual Study Start Date :
Jun 12, 2015
Actual Primary Completion Date :
Aug 31, 2020
Actual Study Completion Date :
Aug 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: iCBT

integrated CBT with computerized cognitive remediation

Behavioral: integrated Cognitive Behavioral Therapy
Novel CBT paradigm for schizophrenia/schizoaffective disorder
Other Names:
  • iCBT
  • Behavioral: Computerized cognitive remediation (CCR)
    Part of the iCBT paradigm, a four month block of bi-weekly computerized cognitive remediation using BrainHQ program.
    Other Names:
  • CCR
  • Other: UC

    usual care

    Other: Usual Care
    The usual care that Veterans receive - not limited in scope (i.e., subjects may participate in any/all available treatments, outside the study condition)
    Other Names:
  • UC
  • Outcome Measures

    Primary Outcome Measures

    1. Workforce Participation Measures [Baseline, mid-treatment (6-months), end of treatment (12-months), and post-treatment (18-months)]

      Measure completed by the independent assessor that evaluates participation in the workforce, including: timing of job attainment, average days worked per week while employed, average hours worked while employed, and total weeks worked while employed.

    Secondary Outcome Measures

    1. Specific Levels of Functioning (SLOF) [Baseline, mid-treatment (6-months), end of treatment (12-months), and post-treatment (18-months)]

      Measure of multiple areas of functional outcome. The SLOF is a self-report behavioral rating scale used to assess mentally ill patients' level of functioning in the community and in mental hospitals. The 30-item scale emphasizes patients' everyday behaviors rather than emotional or mental capacity, and it focuses on patients' tangible strengths and skills rather than on patients' weaknesses.

    2. Work Behavior Inventory [Baseline, mid-treatment (6-months), end of treatment (12-months), and post-treatment (18-months)]

      Measure completed by the supported employment specialist that evaluates work quality in an employment setting.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of DSM-IV schizophrenia or schizoaffective disorder (SCID)

    • Severe/extreme functional disability [World Health Organization Disability Assessment Scale (WHODAS) score > 50]

    • Clinical stability (as per primary mental health provider)

    • Receiving treatment at the Veterans Administration

    • Minimal engagement in psychiatric rehabilitation services (just psychiatrist and therapist/case management in the last 6 months)

    • Eligible for and willing to be enrolled in Supported Employment program

    • Age 18 to 65

    • Proficient in English

    • Able to give informed consent

    Exclusion Criteria:
    • Neurologic disease or damage that would make the diagnosis of schizophrenia questionable

    • Current opioid or stimulant dependence (SCID)

    • Not appropriate due to safety concerns (based on risk assessment)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Philadelphia Pennsylvania United States 19104

    Sponsors and Collaborators

    • VA Office of Research and Development

    Investigators

    • Principal Investigator: Steven L. Sayers, PhD, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    VA Office of Research and Development
    ClinicalTrials.gov Identifier:
    NCT01992913
    Other Study ID Numbers:
    • D1157-R
    First Posted:
    Nov 25, 2013
    Last Update Posted:
    Oct 8, 2020
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by VA Office of Research and Development
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 8, 2020